NCT00411073View on ClinicalTrials.gov

Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

December 31, 2006

Conditions

Atherosclerosis

Interventions

DRUG

Darapladib

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00411073 - Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart | Biotech Hunter | Biotech Hunter